STRATA SKIN SCIENCES, INC. (NASDAQ:SSKN) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On May 10, 2017 James Coyne accepted the invitation extended to him on May 2, 2017 by the Board of Directors of STRATA Skin Sciences, Inc. (the “Company”) to become a member of the Company’s Board of Directors. In addition to his regular duties as a Board member, Mr. Coyne will serve as a member of the Board’s Compensation Committee. Mr. Coyne is currently the CEO of Modevity LLC, a software company he founded in 2004, and which produces the ARALOC™, a market leading digital content distribution program.

The appointment of Mr. Coyne took place on the same day that the Company accepted the resignation of Dr. R. Rox Anderson from his position as a Board member and member of the Board’s Audit Committee. Even though the demands on his time from his professional obligations made it untenable for Dr. Anderson to continue to serve as Board member and member of the Audit Committee, he intends to remain directly involved with the Company as the head of its newly reconstituted Scientific Advisory Board.

Ms. Luann Via, a long-standing member of the Company’s Board, has become a member of the Audit Committee.

In connection with this event, the Company issued a press release, a copy of which is attached as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits

Exhibit No. Exhibit Description

99.1 Press Release dated May 10, 2017

About STRATA SKIN SCIENCES, INC. (NASDAQ:SSKN)
STRATA Skin Sciences, Inc., formerly MELA Sciences, Inc., is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging. The XTRAC and VTRAC products are the devices used for the treatment of psoriasis, vitiligo and other skin disorders. The XTRAC system delivers targeted ultraviolet light to affected areas of skin, leading to psoriasis clearing and vitiligo repigmentation, following a series of treatments. The Company’s technology includes XTRAC Excimer Laser, VTRAC Lamp and MelaFind. MelaFind is a non-invasive, point-of-care instrument to aid dermatologists in their decision to biopsy suspicious pigmented lesions, such as melanoma. The Company has approximately two distribution channels for phototherapy treatment equipment. STRATA SKIN SCIENCES, INC. (NASDAQ:SSKN) Recent Trading Information
STRATA SKIN SCIENCES, INC. (NASDAQ:SSKN) closed its last trading session up +0.05 at 2.80 with 43,739 shares trading hands.